Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


2 Am J Hematol
1 Am J Kidney Dis
3 Ann Hematol
3 Blood
2 BMC Pediatr
3 Br J Haematol
1 Exp Hematol
1 Haematologica
1 Int J Hematol
1 J Pediatr
1 Lancet
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Hematol

  1. POTHAST CR, van Dijk K, Pool ES, Halkes CJM, et al
    SARS-CoV-2 mRNA vaccination of aplastic anemia patients is safe and effective.
    Am J Hematol. 2022 Nov 13. doi: 10.1002/ajh.26780.

  2. ZHANG Y, Zhou H, Jiang Z, Wu D, et al
    Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naive patients with myelofibrosis: Results of a phase II trial.
    Am J Hematol. 2022;97:1510-1519.
    PubMed         Abstract available

    Am J Kidney Dis

  3. ZHENG Q, Wang Y, Yang H, Sun L, et al
    Cardiac and Kidney Adverse Effects of HIF Prolyl-Hydroxylase Inhibitors for Anemia in Patients With CKD Not Receiving Dialysis: A Systematic Review and Meta-analysis.
    Am J Kidney Dis. 2022 Nov 14. pii: S0272-6386(22)01014.
    PubMed         Abstract available

    Ann Hematol

  4. MUSALLAM KM, Cappellini MD, Daar S, El-Beshlawy A, et al
    Magnitude of cumulative iron overload correlates with the severity of anemia in untreated non-transfusion-dependent beta-thalassemia.
    Ann Hematol. 2022 Nov 14. pii: 10.1007/s00277-022-05046.

  5. DELEHAYE F, Rouger J, Brossier D, Suttorp M, et al
    Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course.
    Ann Hematol. 2022 Nov 12. pii: 10.1007/s00277-022-05024.
    PubMed         Abstract available

  6. ZHANG JY, Li Y, Ma YS, Sun XJ, et al
    Clinical characteristics and prognostic factors in intracranial hemorrhage patients with hematological diseases.
    Ann Hematol. 2022;101:2617-2625.
    PubMed         Abstract available


  7. OLUPOT-OLUPOT P, Tomlinson G, Williams TN, Tshilolo LMM, et al
    Hydroxyurea is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa.
    Blood. 2022 Nov 14. pii: 487110. doi: 10.1182/blood.2022017051.
    PubMed         Abstract available

    RBC, heal thyself: PK activators in SCD.
    Blood. 2022;140:2005-2006.

  9. XU JZ, Conrey A, Frey I, Gwaabe E, et al
    A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease.
    Blood. 2022;140:2053-2062.
    PubMed         Abstract available

    BMC Pediatr

  10. BELAY DG, Asratie MH, Kibret AA, Kegnie Shitu, et al
    Individual and community level determinants of iron intake among children 6-59 months old in Ethiopia: multilevel logistic regression analysis.
    BMC Pediatr. 2022;22:661.
    PubMed         Abstract available

  11. TRAORE SG, Kouassi KB, Coulibaly JT, Beckmann J, et al
    Dietary diversity in primary schoolchildren of south-central Cote d'Ivoire and risk factors for non-communicable diseases.
    BMC Pediatr. 2022;22:651.
    PubMed         Abstract available

    Br J Haematol

  12. RODRIGUEZ CORTE J, Candal-Pedreira C, Ruano-Ravina A, Perez-Rios M, et al
    Home-based blood transfusion therapy: A systematic review.
    Br J Haematol. 2022;199:496-506.
    PubMed         Abstract available

  13. OGUNSILE FJ, Stewart KJ, Kanter J, Lanzkron SM, et al
    An evaluation of cardiopulmonary endurance and muscular strength in adults living with sickle cell disease.
    Br J Haematol. 2022;199:597-602.
    PubMed         Abstract available

  14. HAN J, Zhang X, Molokie RE, Njoku FU, et al
    COVID-19 vaccination status and disease burden in patients with sickle cell disease.
    Br J Haematol. 2022;199:e21-e24.

    Exp Hematol

  15. CHI Y, Hu Q, Yang C, Chen M, et al
    Avatrombopag is Effective in Patients with Chemoradiotherapy-Induced Aplastic Anemia: A Single Center, Retrospective Study.
    Exp Hematol. 2022 Nov 15. pii: S0301-472X(22)00807.
    PubMed         Abstract available


  16. LIU YL, Shibuya A, Glader B, Wilkes MC, et al
    Animal models of Diamond-Blackfan anemia: updates and challenges.
    Haematologica. 2022 Nov 17. doi: 10.3324/haematol.2022.282042.
    PubMed         Abstract available

    Int J Hematol

  17. NAKAMURA Y, Mori T, Kako S, Yamazaki H, et al
    Outcome of peripheral blood stem cell transplantation from HLA-identical sibling donors for adult patients with aplastic anemia.
    Int J Hematol. 2022 Nov 15. pii: 10.1007/s12185-022-03487.
    PubMed         Abstract available

    J Pediatr

  18. SAMBHU HEMA L, Gunasekaran PK, Tandon M, Didel S, et al
    Retinopathy of Megaloblastic Anemia: Treatable and Reversible.
    J Pediatr. 2022;250:106-107.


  19. VLACHADIS N, Vrachnis N
    A Review of Sickle Cell Disease.
    JAMA. 2022;328:1979.

  20. KAVANAGH PL, Fasipe T, Wun T
    A Review of Sickle Cell Disease-Reply.
    JAMA. 2022;328:1979-1980.

    Gene Therapy for Sickle Cell Disease, beta-Thalassemia Enters Regulatory Reviews.
    JAMA. 2022;328:1798.


  22. MICHAEL M, Bagga A, Sartain SE, Smith RJH, et al
    Haemolytic uraemic syndrome.
    Lancet. 2022;400:1722-1740.
    PubMed         Abstract available

    PLoS One

  23. LAMONT AE, Hsu LL, Jacobs S, Gibson R, et al
    What does it mean to be affiliated with care?: Delphi consensus on the definition of "unaffiliation" and "specialist" in sickle cell disease.
    PLoS One. 2022;17:e0272204.
    PubMed         Abstract available

  24. ISA HA, Nnebe-Agumadu U, Nwegbu MM, Okocha EC, et al
    Determinants of hydroxyurea use among doctors, nurses and sickle cell disease patients in Nigeria.
    PLoS One. 2022;17:e0276639.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.